CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Sanofi SA - SAN CFD

86.88
2.7%
0.33
最低: 85.25
最高: 87.06
Market Trading Hours* (UTC) Opens on Wednesday at 08:01

Mon - Fri: 08:01 - 16:30

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.33
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024161 %
Charges from borrowed part ($-0.97)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024161%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.020283 %
Charges from borrowed part ($-0.81)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.020283%
隔夜费时间 22:00 (UTC)
最小交易量 1
货币 EUR
保证金 20%
上市交易所 France
交易费 0%

*Information provided by Capital.com

Sanofi SA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 84.6
开盘价* 85.25
1 年变化* -5.1%
日范围* 85.25 - 87.06
52 周范围 76.45-106.10
平均交易量(10 天) 2.03M
平均交易量(3 个月) 39.09M
市值 107.06B
市盈率 15.82
流通股 1.25B
收入 45.39B
EPS 5.37
股息(收益率 %) 3.90134
贝塔 0.46
下一个财报发布日期 Apr 27, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Feb 6, 2023 84.60 0.47 0.56% 84.13 85.16 83.75
Feb 3, 2023 84.69 1.58 1.90% 83.11 86.16 82.05
Feb 2, 2023 86.81 -1.03 -1.17% 87.84 88.57 86.32
Feb 1, 2023 88.64 -1.25 -1.39% 89.89 89.89 88.24
Jan 31, 2023 89.81 0.07 0.08% 89.74 90.46 88.84
Jan 30, 2023 89.75 0.58 0.65% 89.17 90.07 88.72
Jan 27, 2023 89.44 0.54 0.61% 88.90 89.69 88.90
Jan 26, 2023 89.69 -0.57 -0.63% 90.26 90.92 89.57
Jan 25, 2023 89.82 0.48 0.54% 89.34 89.84 88.92
Jan 24, 2023 89.12 -0.67 -0.75% 89.79 89.86 88.74
Jan 23, 2023 89.66 -0.21 -0.23% 89.87 90.00 89.24
Jan 20, 2023 90.51 -0.31 -0.34% 90.82 91.31 90.30
Jan 19, 2023 91.25 -0.06 -0.07% 91.31 91.89 90.29
Jan 18, 2023 91.05 -0.08 -0.09% 91.13 91.54 90.69
Jan 17, 2023 91.75 0.25 0.27% 91.50 91.93 91.23
Jan 16, 2023 91.62 0.25 0.27% 91.37 91.73 90.88
Jan 13, 2023 91.07 0.20 0.22% 90.87 91.55 90.33
Jan 12, 2023 90.27 0.01 0.01% 90.26 91.13 89.01
Jan 11, 2023 89.92 -0.44 -0.49% 90.36 90.65 89.74
Jan 10, 2023 89.94 0.21 0.23% 89.73 91.15 89.63

Sanofi SA Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
总收入 34696 36221 35677 37631 37369 39175
收入 34696 36221 35677 37631 37369 39175
收入成本,共计 10701 11613 11435 11979 12159 12255
毛利 23995 24608 24242 25652 25210 26920
总营业费用 28165 30417 31001 34580 23256 31049
销售/一般/行政费用,总计 9422 10072 9772 9777 9304 9457
研究与开发 5156 5472 5890 6017 5528 5689
Depreciation / Amortization 1769 1866 2264 2262 1774 1681
异常费用(收入) 860 1239 1696 3966 777 235
Other Operating Expenses, Total 257 155 -56 579 1096 1732
营业收入 6531 5804 4676 3051 14113 8126
利息收入(费用),非经营净值 -237 -221 -273 -210 -263 -289
其他,净值 -619 -52 2 -89 -72 -39
税前净收入 5675 5531 4405 2752 13778 7798
税后净收入 4350 3809 3924 2631 11971 6240
少数股东权益 -91 -121 -104 -31 -36 -56
Equity In Affiliates 136 85 499 255 359 39
未计算非常项目前的净收益 4395 3773 4319 2855 12294 6223
非常规项目总计 314 4643 -13 -101 0 0
净收入 4709 8416 4306 2754 12294 6223
普通股股东可获收益 (不含非经常性项目) 4395 3773 4319 2855 12294 6223
普通股股东可获收益 (含非經常性項目) 4709 8416 4306 2754 12294 6223
摊薄调整 -4.52 -4.448
摊薄净收入 4704.48 8411.55 4306 2754 12294 6223
摊薄后加权平均股 1296 1266.8 1255.2 1257.1 1260.1 1257.9
扣除特别项目的每股摊薄盈利 3.38772 2.97486 3.44089 2.2711 9.75637 4.94713
Dividends per Share - Common Stock Primary Issue 2.96 3.03 3.07 3.15 3.2 3.31263
每股正常摊薄盈利 3.89636 3.64841 4.64452 5.28727 10.2921 5.09663
利息费用(收入) - 净运营 0 -7382 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
总收入 8886 17931 10829 21244 10053
收入 8886 17931 10829 21244 10053
收入成本,共计 2684 5541 3238 6714 2880
毛利 6202 12390 7591 14530 7173
总营业费用 6828 14318 7787 16731 7656
销售/一般/行政费用,总计 2194 4530 2267 5025 2379
研究与开发 1266 2663 1443 3029 1489
Depreciation / Amortization 389 775 385 805 449
异常费用(收入) 158 505 170 512 198
Other Operating Expenses, Total 137 304 284 646 261
营业收入 2058 3613 3042 4513 2397
利息收入(费用),非经营净值 -85 -155 -85 -153 -78
税前净收入 1973 3452 2957 4346 2319
税后净收入 1569 2770 2348 3470 1987
少数股东权益 -12 -20 -26 -36 -8
Equity In Affiliates 9 26 -5 13 30
未计算非常项目前的净收益 1566 2776 2317 3447 2009
净收入 1566 2776 2317 3447 2009
普通股股东可获收益 (不含非经常性项目) 1566 2776 2317 3447 2009
普通股股东可获收益 (含非經常性項目) 1566 2776 2317 3447 2009
摊薄净收入 1566 2776 2317 3447 2009
摊薄后加权平均股 1249.3 1255.6 1254.5 1260.2 1249.2
扣除特别项目的每股摊薄盈利 1.2535 2.2109 1.84695 2.73528 1.60823
Dividends per Share - Common Stock Primary Issue 0 0 0 3.31263 0
每股正常摊薄盈利 1.35408 2.53363 1.95455 3.05967 1.74404
利息费用(收入) - 净运营 0 0 0
其他,净值 -6 -14
非常规项目总计 0
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
流动资产总额 26691 26354 24579 28611 33703 30564
现金和短期投资 10304 10315 7124 9853 14815 11152
Cash 1077 661 701 1144 1358
现金等价物 9196 10315 6264 8726 12771 8740
短期投资 31 199 426 900 1054
应收账款总额,净额 9050 7216 9345 10083 9953 9787
Accounts Receivable - Trade, Net 7311 7216 7260 7937 7491 7568
Total Inventory 6896 6818 7477 7994 8352 8715
Prepaid Expenses 333 469 493 525 615
Other Current Assets, Total 108 2005 164 188 58 295
Total Assets 104679 99813 111408 112630 114413 120242
Property/Plant/Equipment, Total - Net 10019 9579 9651 11017 10563 11976
Property/Plant/Equipment, Total - Gross 21877 22697 25151 24880 27555
Accumulated Depreciation, Total -11858 -13046 -14134 -14317 -15579
Goodwill, Net 40287 40264 44235 44519 44364 48056
Intangibles, Net 10879 13080 21889 16509 18341 21407
Long Term Investments 4906 5428 5550 5303 2129 2425
Note Receivable - Long Term 776 730 746 521 537 485
Other Long Term Assets, Total 11121 4378 4758 6150 4776 5329
Total Current Liabilities 16443 15463 17376 20381 19248 21295
Accounts Payable 4297 4633 5041 5313 5295 6180
Accrued Expenses 1967 1989 1978 2042 2126
Notes Payable/Short Term Debt 203 237 249 305 285 189
Current Port. of LT Debt/Capital Leases 1561 1038 2364 4508 2714 3263
Other Current Liabilities, Total 8415 9555 7733 8277 8912 9537
Total Liabilities 47127 41743 52532 53574 51307 51561
Total Long Term Debt 16765 14309 22071 21168 20725 19015
Long Term Debt 16731 14289 22053 20181 19794 17176
Capital Lease Obligations 34 20 18 987 931 1839
Deferred Income Tax 2292 1605 3414 2294 1770 1617
Minority Interest 170 169 159 174 146 350
Other Liabilities, Total 11457 10197 9512 9557 9418 9284
Total Equity 57552 58070 58876 59056 63106 68681
Common Stock 2584 2508 2495 2508 2518 2527
Additional Paid-In Capital 51475 52862 53106 52049 60511 63545
Treasury Stock - Common -1503 -14 -153 -9 -705 -939
Other Equity, Total 4996 2714 3428 4508 782 3548
Total Liabilities & Shareholders’ Equity 104679 99813 111408 112630 114413 120242
Total Common Shares Outstanding 1271.94 1253.85 1245.45 1253.83 1250.69 1252.54
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流动资产总额 29502 30564
现金和短期投资 9722 10098
现金等价物 9722 10098
应收账款总额,净额 7425 8180
Accounts Receivable - Trade, Net 6802 7568
Total Inventory 9261 8715
Other Current Assets, Total 3094 3571
Total Assets 112321 120242
Property/Plant/Equipment, Total - Net 10976 11976
Goodwill, Net 44979 48056
Intangibles, Net 19466 21407
Long Term Investments 2149 2425
Note Receivable - Long Term 508 485
Other Long Term Assets, Total 4741 5329
Total Current Liabilities 19127 21295
Accounts Payable 5374 6180
Notes Payable/Short Term Debt 152 189
Current Port. of LT Debt/Capital Leases 2320 3263
Other Current Liabilities, Total 11281 11663
Total Liabilities 49084 51561
Total Long Term Debt 19226 19015
Long Term Debt 17984 17176
Capital Lease Obligations 1242 1839
Deferred Income Tax 1674 1617
Minority Interest 127 350
Other Liabilities, Total 8930 9284
Total Equity 63237 68681
Common Stock 2522 2527
Additional Paid-In Capital 362 63545
Retained Earnings (Accumulated Deficit) 59046
Treasury Stock - Common -697 -939
Other Equity, Total 2004 3548
Total Liabilities & Shareholders’ Equity 112321 120242
Total Common Shares Outstanding 1252.54 1252.54
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
净收入/起跑线 4709 8416 4306 2754 12294 6223
经营活动产生的现金 7853 7379 5547 7715 7418 10522
经营活动产生的现金 3301 3686 4279 7445 3671 3351
Deferred Taxes -542 -909 -727 -1772 -221 -356
非现金物品 -112 -3961 -1031 -293 -8001 -105
Cash Taxes Paid 2096 1734 2058 1695 2051 1280
已付现金利息 401 347 412 379 315 334
营运资金的变化 497 147 -1280 -419 -325 1409
投资活动产生的现金 -2637 639 -12872 -1029 3619 -7298
资本支出 -2083 -1956 -1977 -1787 -2083 -2043
其他投资现金流量项目,总计 -554 2595 -10895 758 5702 -5255
融资活动产生的现金 -3990 -7902 3934 -4193 -6485 -7056
融资现金流项目 79 -52 -91 -21 -44 -48
Total Cash Dividends Paid -3759 -3710 -3773 -3834 -3937 -4008
股票的发行(报废),净额 -2603 -1843 -924 153 -619 -196
债务的发行(退还),净额 2293 -2297 8722 -491 -1885 -2804
外汇效应 -101 -74 1 9 -64 15
现金净变化 1125 42 -3390 2502 4488 -3817
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 2776 6223
Cash From Operating Activities 4754 10522
Cash From Operating Activities 1726 3351
Deferred Taxes -134 -356
Non-Cash Items -149 -105
Cash Taxes Paid 220 1280
Cash Interest Paid 180 334
Changes in Working Capital 535 1409
Cash From Investing Activities -2339 -7298
Capital Expenditures -1018 -2043
Other Investing Cash Flow Items, Total -1321 -5255
Cash From Financing Activities -6616 -7056
Financing Cash Flow Items -41 -48
Total Cash Dividends Paid -4008 -4008
Issuance (Retirement) of Stock, Net -117 -196
Issuance (Retirement) of Debt, Net -2450 -2804
Foreign Exchange Effects 8 15
Net Change in Cash -4193 -3817
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
L'Oreal SA Corporation 9.3769 118227307 0 2022-01-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 7.3618 92820373 -109952 2022-12-01 LOW
Dodge & Cox Investment Advisor/Hedge Fund 5.032 63444721 703109 2022-10-10 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.5834 32572709 74521 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.1068 26563280 1278355 2022-12-31 LOW
Sanofi SA Employees Corporation 1.8586 23433679 -566855 2022-01-31 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 1.6609 20941703 182699 2022-12-31 HIGH
T. Rowe Price Associates, Inc. Investment Advisor 1.3756 17344626 -233 2022-12-01 LOW
Fidelity International Investment Advisor 1.0165 12816070 7228 2022-12-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.9217 11620994 33830 2022-12-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 0.8705 10976049 9625458 2022-11-30 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.8122 10240514 -115847 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.667 8409239 4 2023-01-31 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 0.6576 8291246 -485613 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.5622 7088532 -13850 2022-12-31 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 0.5523 6964128 59807 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.5327 6716234 -321183 2022-12-31 LOW
First Eagle Investment Management, L.L.C. Investment Advisor/Hedge Fund 0.5248 6616420 -237452 2022-12-31 LOW
BNP Paribas Asset Management France SAS Investment Advisor/Hedge Fund 0.5136 6475740 -375463 2022-12-31 LOW
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.4688 5910243 6677 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group
+500000+

交易者

93000+

每月活跃客户

$57000000+

每月投资额

$31000000+

每月提取金额

交易計算器

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

貿易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
杠杆
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Sanofi Company profile

关于 Sanofi SA

赛诺菲公司是一家总部设在法国的医疗保健公司。 公司专注于病人的需求,从事治疗方案的研究、开发、制造和营销。 它的三个运营部门是。 医药、消费者保健(CHC)和疫苗。 制药部门包括。 免疫学、多发性硬化症/神经学、肿瘤学、罕见疾病、罕见血液病、心血管病、糖尿病、成熟的处方药产品。 疫苗业务包括所有地区的赛诺菲巴斯德公司的商业运作,以及专门用于疫苗的研究、开发和生产活动。 CHC业务包括赛诺菲消费者保健产品的商业运作,以及专门用于这些产品的研究、开发和生产活动。 公司合作开发或特许经营的产品包括Dupixent、Aubagio、Lemtrada、Cerezyme、Lumizyme、Jevtana、Fabrazyme,等等。

Industry: Pharmaceuticals (NEC)

54 Rue la Boétie
PARIS
ILE-DE-FRANCE 75008
FR

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

77.63 Price
+3.990% 1D Chg, %
多头隔夜费 -0.0221%
空头隔夜费 0.0069%
隔夜费时间 22:00 (UTC)
价差 0.03

US100

12,711.50 Price
+1.980% 1D Chg, %
多头隔夜费 -0.0187%
空头隔夜费 0.0075%
隔夜费时间 22:00 (UTC)
价差 1.8

XRP/USD

0.41 Price
+1.680% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 0.00426

Natural Gas

2.62 Price
+3.850% 1D Chg, %
多头隔夜费 -0.1070%
空头隔夜费 0.0755%
隔夜费时间 22:00 (UTC)
价差 0.006

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易